Form 8-K - Current report:
SEC Accession No. 0001683168-20-001127
Filing Date
2020-04-08
Accepted
2020-04-08 08:00:36
Documents
4
Period of Report
2020-04-06
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pharmacyte_8k.htm 8-K 21174
2 PHARMACYTE BIOTPRESS RELEASE pharmacyte_ex9901.htm EX-99.1 14429
3 LICENSE AGREEMENT pharmacyte_ex9902.htm EX-99.2 183465
4 GRAPHIC logo.jpg GRAPHIC 5647
  Complete submission text file 0001683168-20-001127.txt   228328
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 333-68008 | Film No.: 20781117
SIC: 2836 Biological Products, (No Diagnostic Substances)